Latest Breaking News On - Dynamx coronary drug eluting bioadaptor - Page 1 : comparemela.com

Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).

United statesFrance generalMotasim sirhanDevelopment of the dynamx bioadaptorElixir medical corporationElixir medicalDynamx coronary drug eluting bioadaptorResolute onyx drug eluting stentTarget lesion failureResolute onyxDynamx bioadaptorClinical safetyDynamx coronary bioadaptor system